The Wall Street Journal reports, The supposed bomber at the center of a foiled plot to bring down a jetliner, was actually a double agent who funneled vital information to U.S. and Arab intelligence agencies, according to officials, marking an apparently successful infiltration of al Qaeda’s most dangerous branch. The revelation came a day after U.S. officials said, the Central Intelligence Agency, working with foreign security services and other agencies, had thwarted a bomb plot by al Qaeda’s Yemeni branch, aimed at bringing down a U.S. jetliner, with a more advanced version of an underwear bomb used in a failed 2009 Christmas Day attempt. The bomb that was recovered, in the latest suicide bomb attack, has two detonators, providing a crucial backup in the event one failed. Investigators are closely scrutinizing the construction of the bomb for clues that would lead to its makers and would also help aviation security experts improve and adjust airport detection systems.
The Wall Street Journal also reports, GlaxoSmithKline said it would take its unsolicited $2.6 billion bid for Human Genome Sciences, directly to the biotech’s shareholders this week, a hostile move that will test Glaxo’s long-standing partnership, with the smaller firm. Human Genome Sciences, last month rejected Glaxo’s $13-a-share offer as too low, and said it had hired two banks to advise it, on “strategic alternatives,” including a possible sale of the company. Glaxo and Human Genome Sciences jointly sell a drug for lupus, that they developed together, and share financial interest in drugs for diabetes and heart disease.
Bloomberg reports, some of the world’s largest wealth-management firms are starting to reject American Millionairies, ahead of Washington’s implementation of the Foreign Account Tax Compliance Act, known as Fatca, which seeks to prevent tax evasion by Americans with offshore accounts. HSBC Holdings, Deutsche Bank, Bank of Singapore and DBS Group Holdings, all say they have turned away business. The 2010 law, to be phased in starting Jan. 1, 2013, requires financial institutions based outside the U.S., to obtain and report information, about income and interest payments, accrued to the accounts of American clients. It means additional compliance costs for banks and fewer investment options and advisers for all U.S. citizens living abroad, which could affect their ability to generate returns. Renouncing citizenship is an option chosen by increasing numbers of Americans. A record 1,780 gave up their U.S. passports last year, compared with 235 in 2008, as reported by the IRS.
The Wall Street Journal reports, The supposed bomber at the center of a foiled plot to bring down a jetliner, was actually a double agent who funneled vital information to U.S. and Arab intelligence agencies, according to officials, marking an apparently successful infiltration of al Qaeda’s most dangerous branch. The revelation came a day after U.S. officials said, the Central Intelligence Agency, working with foreign security services and other agencies, had thwarted a bomb plot by al Qaeda’s Yemeni branch, aimed at bringing down a U.S. jetliner, with a more advanced version of an underwear bomb used in a failed 2009 Christmas Day attempt. The bomb that was recovered, in the latest suicide bomb attack, has two detonators, providing a crucial backup in the event one failed. Investigators are closely scrutinizing the construction of the bomb for clues that would lead to its makers and would also help aviation security experts improve and adjust airport detection systems.
The Wall Street Journal also reports, GlaxoSmithKline said it would take its unsolicited $2.6 billion bid for Human Genome Sciences, directly to the biotech’s shareholders this week, a hostile move that will test Glaxo’s long-standing partnership, with the smaller firm. Human Genome Sciences, last month rejected Glaxo’s $13-a-share offer as too low, and said it had hired two banks to advise it, on “strategic alternatives,” including a possible sale of the company. Glaxo and Human Genome Sciences jointly sell a drug for lupus, that they developed together, and share financial interest in drugs for diabetes and heart disease.
Bloomberg reports, some of the world’s largest wealth-management firms are starting to reject American Millionairies, ahead of Washington’s implementation of the Foreign Account Tax Compliance Act, known as Fatca, which seeks to prevent tax evasion by Americans with offshore accounts. HSBC Holdings, Deutsche Bank, Bank of Singapore and DBS Group Holdings, all say they have turned away business. The 2010 law, to be phased in starting Jan. 1, 2013, requires financial institutions based outside the U.S., to obtain and report information, about income and interest payments, accrued to the accounts of American clients. It means additional compliance costs for banks and fewer investment options and advisers for all U.S. citizens living abroad, which could affect their ability to generate returns. Renouncing citizenship is an option chosen by increasing numbers of Americans. A record 1,780 gave up their U.S. passports last year, compared with 235 in 2008, as reported by the IRS.